Establishment of Cohort Under the Guidance of the Pathogenesis of Cancer Toxin in Traditional Chinese Medicine

Launched by YING ZHANG · Sep 22, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on understanding how the bacteria in our bodies, known as microbiota, interact with tumors and possibly influence the development of cancer. Researchers will collect health information and biological samples from both healthy individuals and cancer patients to explore these interactions further. The goal is to learn more about how these relationships may contribute to cancer.

To be eligible for the study, participants need to be at least 18 years old and provide informed consent. Healthy individuals should not have any history of cancer or significant health issues, while cancer patients must have a confirmed diagnosis and meet specific treatment criteria. Participants can expect to be involved in providing health information and samples, helping researchers gain insights that could lead to better understanding and treatment options for cancer in the future. The trial is currently not recruiting participants, so it will begin at a later date.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• Inclusion criteria for healthy individuals:
• • Age ≥ 18 years old;
• • Informed consent and signed informed consent form.
• Inclusion criteria for patients with malignant tumors:
• • Patients with malignant tumors diagnosed by pathology or cytology;
• • Advanced stage patients who have not received modern medical treatment in the past, or early to mid-stage patients who have completed postoperative radiochemotherapy for ≥ 1 month;
• • Age ≥ 18 years old;
• • Informed consent and signed informed consent form.
• Exclusion Criteria:
• Exclusion criteria for healthy individuals:
• • Patients with malignant tumors diagnosed by pathology or cytology;
• • Those who have taken any antibiotics/probiotics within 1 month before biological sample collection;
• • Those with other immune or infectious diseases;
• • Those with severe damage to the heart, liver, lungs, or kidney functions;
• • Pregnant women, or those with mental illnesses such as depression or schizophrenia;
• • Those deemed ineligible for the study by the researcher.
• Exclusion criteria for patients with malignant tumors:
• • Patients with multiple primary cancers;
• • Those who have taken any antibiotics/probiotics within 1 month before biological sample collection;
• • Those with other immune or infectious diseases;
• • Those with severe damage to the heart, liver, lungs, or kidney functions;
• • Pregnant women, or those with mental illnesses such as depression or schizophrenia;
• • Those deemed ineligible for the study by the researcher.